Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000166947 | SCV000217767 | likely benign | Hereditary cancer-predisposing syndrome | 2014-11-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000166947 | SCV000904743 | likely benign | Hereditary cancer-predisposing syndrome | 2018-09-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000952587 | SCV001099102 | likely benign | Ataxia-telangiectasia syndrome | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001174986 | SCV001338476 | likely benign | not specified | 2020-04-17 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000166947 | SCV002537856 | likely benign | Hereditary cancer-predisposing syndrome | 2021-10-02 | criteria provided, single submitter | curation | |
Myriad Genetics, |
RCV004589812 | SCV005083979 | benign | Familial cancer of breast | 2024-06-18 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |